Moderna | MRNA - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
Acadia Pharmaceuticals USD 146.88M 1.69M 2026-09
Agios Pharmaceuticals USD 51.55M 13.09M 2026-06
Alnylam Pharmaceuticals USD 342M 5.92M 2026-09
Amgen USD 1.68B 40M 2026-09
Arrowhead Research USD 46.63M 4.88M 2026-06
Biogen USD 752M 42.3M 2026-09
BioMarin Pharmaceutical USD 333.64M 61.91M 2026-09
Celltrion KRW 12.72B 3.4B 2026-06
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 13.56M 1.09M 2026-06
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Gilead Sciences USD 1.52B 70M 2026-06
GlaxoSmithKline GBP 2.16B 39M 2026-09
Incyte USD 364.27M 12.54M 2026-09
Ionis Pharmaceuticals USD 130.07M 20.92M 2026-06
Kangmei Pharma CNY 253.72M 16.66M 2026-06
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Moderna USD 216M 43M 2026-06
Organigram Holdings CAD 26.51M 4.5M 2026-06
Ovoca Bio EUR 617K 15K 2025-12
Pharma Mar EUR 15.53M 1.59M 2026-09
Puma Biotechnology USD 16.82M 8.15M 2024-09
Qiagen NV USD 142.33M 60K 2026-06
Regeneron Pharmaceuticals USD 662.1M 14.4M 2026-06
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sarepta Therapeutics USD 107.6M 53.57M 2026-06
Sartorius EUR 216.6M 4.7M 2026-09
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Tilray USD 24.85M 1.7M 2025-09
Ultragenyx Pharmaceutical USD 97M 9M 2026-09
United Therapeutics USD 184.1M 22.6M 2026-09
Vertex Pharmaceuticals USD 556.3M 25.9M 2026-09
Zealand Pharma A/S 104M 12.19M 2026-03
Zz Pientze Pharmaceu CNY 267.85M 44.71M 2026-09